Register entry
AGC Biologics, Inc.
- Registered sites
- 7
- Drug products
- 12
- Live patents
- 0
- Countries
- 5
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureFinished drug manufacture
Sites
Facilities
7| Site | Location | Operations | FEI |
|---|---|---|---|
| AGC Biologics GmbH | HeidelbergGermany | Analytical testing | 3003323027 |
| AGC Biologics A/S | SoeborgDenmark | Analytical testing, Active ingredient (API) manufacture | 3004708748 |
| AGC Biologics SPA | BressoItaly | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3020270660 |
| AGC Inc. | IchiharaJapan | Active ingredient (API) manufacture | 3003282601 |
| AGC Biologics, Inc. | Bothell, WAUnited States | Analytical testing, Active ingredient (API) manufacture | 3000209996 |
| AGC Biologics Inc. | Boulder, COUnited States | Analytical testing, Active ingredient (API) manufacture | 3018698628 |
| AGC Biologics Inc. | Longmont, COUnited States | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3020775398 |
Catalogue
Marketed products
12Showing 12 of 12.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | AFLIBERCEPT | SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | ASPARAGINASE ERWINIA CHRYSANTHEMI | SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | AXATILIMAB | SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | COAGULATION FACTOR IX RECOMBINANT HUMAN | SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | ETUVETIDIGENE AUTOTEMCEL | SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | NOGAPENDEKIN ALFA | SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Perfluorhexlyoctane | LIQUID | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | TEBENTAFUSP | SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | TEPLIZUMAB | SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | TEPROTUMUMAB | SOLUTION | DRUG FOR FURTHER PROCESSING |
| - | Tafluprost | SOLUTION | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Ustekinumab | SOLUTION | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.